Functional mapping of androgen receptor enhancer activity

Background Androgen receptor (AR) is critical to the initiation, growth, and progression of prostate cancer. Once activated, the AR binds to cis-regulatory enhancer elements on DNA that drive gene expression. Yet, there are 10–100× more binding sites than differentially expressed genes. It is unclear how or if these excess binding sites impact gene transcription. Results To characterize the regulatory logic of AR-mediated transcription, we generated a locus-specific map of enhancer activity by functionally testing all common clinical AR binding sites with Self-Transcribing Active Regulatory Regions sequencing (STARRseq). Only 7% of AR binding sites displayed androgen-dependent enhancer activity. Instead, the vast majority of AR binding sites were either inactive or constitutively active enhancers. These annotations strongly correlated with enhancer-associated features of both in vitro cell lines and clinical prostate cancer samples. Evaluating the effect of each enhancer class on transcription, we found that AR-regulated enhancers frequently interact with promoters and form central chromosomal loops that are required for transcription. Somatic mutations of these critical AR-regulated enhancers often impact enhancer activity. Conclusions Using a functional map of AR enhancer activity, we demonstrated that AR-regulated enhancers act as a regulatory hub that increases interactions with other AR binding sites and gene promoters.

[1]  Faraz Hach,et al.  Functional mapping of androgen receptor enhancer activity , 2021, Genome Biology.

[2]  Howard Y. Chang,et al.  ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis , 2021, Nature Genetics.

[3]  Howard Y. Chang,et al.  ArchR: An integrative and scalable software package for single-cell chromatin accessibility analysis , 2020, bioRxiv.

[4]  Ryan M. Layer,et al.  Regulatory sharing between estrogen receptor α bound enhancers , 2020, bioRxiv.

[5]  Zhuqiang Zhang,et al.  Histone H3K27 acetylation is dispensable for enhancer activity in mouse embryonic stem cells , 2020, Genome Biology.

[6]  Nuno A. Fonseca,et al.  Analyses of non-coding somatic drivers in 2,658 cancer whole genomes , 2020, Nature.

[7]  Jun Yu,et al.  Analyses of non-coding somatic drivers in 2,658 cancer whole genomes , 2020, Nature.

[8]  Takafumi N. Yamaguchi,et al.  Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors. , 2019, Cancer cell.

[9]  M. Beato,et al.  C/EBPα mediates the growth inhibitory effect of progestins on breast cancer cells , 2019, The EMBO journal.

[10]  C. Coarfa,et al.  The genomic landscape of estrogen receptor α binding sites in mouse mammary gland , 2019, PloS one.

[11]  J. Carroll,et al.  Comprehensive Genomic Analysis Reveals that the Pioneering Function of FOXA1 Is Independent of Hormonal Signaling , 2019, Cell reports.

[12]  Sreejith J. Nair,et al.  Phase separation of ligand-activated enhancers licenses cooperative chromosomal enhancer assembly , 2019, Nature Structural & Molecular Biology.

[13]  Nicola J. Rinaldi,et al.  An AR-ERG transcriptional signature defined by long-range chromatin interactomes in prostate cancer cells , 2019, Genome research.

[14]  P. Kantoff,et al.  Low Expression of the Androgen-Induced Tumor Suppressor Gene PLZF and Lethal Prostate Cancer , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[15]  H. G. van der Poel,et al.  Optimized ChIP-seq method facilitates transcription factor profiling in human tumors , 2018, Life Science Alliance.

[16]  Luca Pinello,et al.  CRISPR-SURF: discovering regulatory elements by deconvolution of CRISPR tiling screen data , 2018, bioRxiv.

[17]  Jun Sese,et al.  ChIP‐Atlas: a data‐mining suite powered by full integration of public ChIP‐seq data , 2018, EMBO reports.

[18]  L. Wessels,et al.  Integrative epigenetic taxonomy of primary prostate cancer , 2018, Nature Communications.

[19]  Joshua M. Stuart,et al.  Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer , 2018, Cell.

[20]  Andrew C. Adey,et al.  Cicero Predicts cis-Regulatory DNA Interactions from Single-Cell Chromatin Accessibility Data. , 2018, Molecular cell.

[21]  Joshua M. Stuart,et al.  Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer , 2018, Cell.

[22]  Christopher W. Whelan,et al.  Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing , 2018, Cell.

[23]  Henry W. Long,et al.  A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer , 2018, Cell.

[24]  Yi Mi Wu,et al.  The long tail of oncogenic drivers in prostate cancer , 2018, Nature Genetics.

[25]  L. Wessels,et al.  Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis , 2018, Oncogene.

[26]  Łukasz M. Boryń,et al.  Resolving systematic errors in widely-used enhancer activity assays in human cells , 2017, Nature Methods.

[27]  A. Gursoy,et al.  Androgen receptor binding sites are highly mutated in prostate cancer , 2017, bioRxiv.

[28]  K. White,et al.  Functional assessment of human enhancer activities using whole-genome STARR-sequencing , 2017, Genome Biology.

[29]  William J. Greenleaf,et al.  chromVAR: Inferring transcription factor-associated accessibility from single-cell epigenomic data , 2017, Nature Methods.

[30]  Icgc,et al.  Pan-cancer analysis of whole genomes , 2017, bioRxiv.

[31]  André F. Rendeiro,et al.  Functional Dissection of the Enhancer Repertoire in Human Embryonic Stem Cells , 2017, bioRxiv.

[32]  S. Q. Xie,et al.  Complex multi-enhancer contacts captured by Genome Architecture Mapping (GAM) , 2017, Nature.

[33]  E. Niskanen,et al.  Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-κB cistrome to reprogram the prostate cancer cell transcriptome , 2016, Nucleic acids research.

[34]  C. Cordon-Cardo,et al.  The role of GATA2 in lethal prostate cancer aggressiveness , 2017, Nature Reviews Urology.

[35]  T. Mikkelsen,et al.  Genome-scale high-resolution mapping of activating and repressive nucleotides in regulatory regions , 2016, Nature Biotechnology.

[36]  Ian C. McDowell,et al.  Direct GR Binding Sites Potentiate Clusters of TF Binding across the Human Genome , 2016, Cell.

[37]  Nicholas A. Sinnott-Armstrong,et al.  Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer , 2016, Nature Genetics.

[38]  Michael T. McManus,et al.  A systematic comparison reveals substantial differences in chromosomal versus episomal encoding of enhancer activity , 2016, bioRxiv.

[39]  Richard Bonneau,et al.  Active and Inactive Enhancers Cooperate to Exert Localized and Long-Range Control of Gene Regulation. , 2016, Cell reports.

[40]  Fidel Ramírez,et al.  deepTools2: a next generation web server for deep-sequencing data analysis , 2016, Nucleic Acids Res..

[41]  Klaus Hansen,et al.  An interactive environment for agile analysis and visualization of ChIP-sequencing data , 2016, Nature Structural &Molecular Biology.

[42]  Danai Koutra,et al.  DeltaCon: Principled Massive-Graph Similarity Function with Attribution , 2016, ACM Trans. Knowl. Discov. Data.

[43]  B. Lenhard,et al.  GenomicInteractions: An R/Bioconductor package for manipulating and investigating chromatin interaction data , 2015, BMC Genomics.

[44]  Steven J. M. Jones,et al.  The Molecular Taxonomy of Primary Prostate Cancer , 2015, Cell.

[45]  Henry W. Long,et al.  The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis , 2015, Nature Genetics.

[46]  David C. Smith,et al.  Integrative Clinical Genomics of Advanced Prostate Cancer , 2015, Cell.

[47]  P. Kantoff,et al.  PLZF, a tumor suppressor genetically lost in metastatic castration-resistant prostate cancer, is a mediator of resistance to androgen deprivation therapy. , 2015, Cancer research.

[48]  Lawrence D. True,et al.  Integrative Clinical Genomics of Advanced Prostate Cancer , 2015, Cell.

[49]  P. Unger,et al.  Loss of PLZF Expression in Prostate Cancer by Immunohistochemistry Correlates with Tumor Aggressiveness and Metastasis , 2015, PloS one.

[50]  Michael Q. Zhang,et al.  Integrative analysis of 111 reference human epigenomes , 2015, Nature.

[51]  O. Jänne,et al.  SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin , 2014, Nucleic acids research.

[52]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[53]  A. Quinlan BEDTools: The Swiss‐Army Tool for Genome Feature Analysis , 2014, Current protocols in bioinformatics.

[54]  K. Tan,et al.  Global view of enhancer–promoter interactome in human cells , 2014, Proceedings of the National Academy of Sciences.

[55]  P. Kantoff,et al.  Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation , 2014, Proceedings of the National Academy of Sciences.

[56]  T. Meehan,et al.  An atlas of active enhancers across human cell types and tissues , 2014, Nature.

[57]  Simon G. Coetzee,et al.  Comprehensive Functional Annotation of 77 Prostate Cancer Risk Loci , 2014, PLoS genetics.

[58]  S. Vowler,et al.  Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype , 2013, Oncogene.

[59]  J. Li,et al.  PLZF Mediates the PTEN/AKT/FOXO3a Signaling in Suppression of Prostate Tumorigenesis , 2013, PloS one.

[60]  Yan Li,et al.  A high-resolution map of three-dimensional chromatin interactome in human cells , 2013, Nature.

[61]  Luke A. Gilbert,et al.  CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.

[62]  David A. Orlando,et al.  Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.

[63]  Łukasz M. Boryń,et al.  Genome-Wide Quantitative Enhancer Activity Maps Identified by STARR-seq , 2013, Science.

[64]  I. Mills,et al.  The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man. , 2013, Cancer cell.

[65]  Nathan C. Sheffield,et al.  Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificity , 2012, Genome Biology.

[66]  Jun S. Song,et al.  Statistical Applications in Genetics and Molecular Biology Normalization , bias correction , and peak calling for ChIP-seq , 2012 .

[67]  C. Lo,et al.  Shrimp Pm-fortilin inhibits the expression of early and late genes of white spot syndrome virus (WSSV) in an insect cell model. , 2011, Developmental and comparative immunology.

[68]  Pedro M. Valero-Mora,et al.  ggplot2: Elegant Graphics for Data Analysis , 2010 .

[69]  Galt P. Barber,et al.  BigWig and BigBed: enabling browsing of large distributed datasets , 2010, Bioinform..

[70]  C. Glass,et al.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.

[71]  Zhaohui S. Qin,et al.  An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. , 2010, Cancer cell.

[72]  Clifford A. Meyer,et al.  Nucleosome Dynamics Define Transcriptional Enhancers , 2010, Nature Genetics.

[73]  Aaron R. Quinlan,et al.  Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .

[74]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[75]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[76]  H. Scher,et al.  Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer , 2009, Science.

[77]  V. Mladenova,et al.  Organization of Plasmid DNA into Nucleosome-Like Structures after Transfection in Eukaryotic Cells , 2009 .

[78]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[79]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[80]  Z. Weng,et al.  High-Resolution Mapping and Characterization of Open Chromatin across the Genome , 2008, Cell.

[81]  K. Pienta,et al.  A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. , 2007, Molecular cell.

[82]  Nathaniel D. Heintzman,et al.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome , 2007, Nature Genetics.

[83]  Zhou Wang,et al.  Identification and characterization of PLZF as a prostatic androgen‐responsive gene , 2004, The Prostate.

[84]  C. Heinlein,et al.  Androgen receptor in prostate cancer. , 2004, Endocrine reviews.

[85]  D. Hartl,et al.  Genetic applications of an inverse polymerase chain reaction. , 1988, Genetics.

[86]  J. Banerji,et al.  Expression of a β-globin gene is enhanced by remote SV40 DNA sequences , 1981, Cell.

[87]  J. Banerji,et al.  Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. , 1981, Cell.